Trial Profile
Efficacy and long term safety of fenfluramine in patients with Dravet syndrome
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 12 Sep 2018
Price :
$35
*
At a glance
- Drugs Fenfluramine (Primary) ; Valproate
- Indications Dravet syndrome
- Focus Therapeutic Use
- 30 Aug 2018 Results presented in a Zogenix media release.
- 30 Aug 2018 According to a Zogenix media release, results (n=15) from this study were presented at the 13th European Congress on Epileptology (ECE).
- 23 Nov 2016 According to a Zogenix media release, new data will be presented at 70th Annual American Epilepsy Society Meeting.